Severe Aspergillus endocarditis in a lung transplant recipient with a five-year survival.
We report the case of a patient with cystic fibrosis who underwent lung transplant and developed Aspergillus endocarditis and cutaneous relapse. Long-term survival was achieved with surgical and prolonged antifungal treatment. This case report emphasizes the recommendation of life-long antifungal treatment in transplant recipients who survive an episode of fungal endocarditis.
Philippe
B
B
Department of Pulmonary Transplantation, Foch Hospital, Suresnes, France. bruno.philippe@ch-pontoise.fr
Grenet
D
D
Honderlick
P
P
Longchampt
E
E
Dupont
B
B
Picard
C
C
Stern
M
M
D000328:Adult; D000935:Antifungal Agents / Q000627:therapeutic use*; D001228:Aspergillosis / Q000188:drug therapy / Q000382:microbiology* / Q000601:surgery; D001232:Aspergillus fumigatus / Q000187:drug effects / Q000302:isolation & purification*; D003550:Cystic Fibrosis / Q000382:microbiology*; D004696:Endocarditis / Q000188:drug therapy / Q000382:microbiology* / Q000601:surgery; D005260:Female; D006801:Humans; D016040:Lung Transplantation / Q000009:adverse effects*; D012720:Severity of Illness Index; D016019:Survival Analysis; D016896:Treatment Outcome
D000935:Antifungal Agents